Approval · Notice of Compliance 23565 · 2020
IFEX: Notice of Compliance 23565
Issued May 6, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23565
- Date
- May 6, 2020
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Changes to carton and vial labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IFEX | Not yet assigned | — |
Medicinal ingredients
- IFOSFAMIDE 1 G per VIAL
- IFOSFAMIDE 3 G per VIAL